{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:48:26Z","timestamp":1791236906791,"version":"4.1.0"},"reference-count":46,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T00:00:00Z","timestamp":1526947200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["G0D6817N"],"award-info":[{"award-number":["G0D6817N"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["056\/2012"],"award-info":[{"award-number":["056\/2012"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007815","name":"District of Columbia Developmental Center for AIDS Research","doi-asserted-by":"publisher","award":["P30AI087714"],"award-info":[{"award-number":["P30AI087714"]}],"id":[{"id":"10.13039\/100007815","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007815","name":"District of Columbia Developmental Center for AIDS Research","doi-asserted-by":"publisher","award":["P30AI117970"],"award-info":[{"award-number":["P30AI117970"]}],"id":[{"id":"10.13039\/100007815","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["04\/15856-9\/EGK"],"award-info":[{"award-number":["04\/15856-9\/EGK"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2010\/05845-0\/EGK\/DFN"],"award-info":[{"award-number":["2010\/05845-0\/EGK\/DFN"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2018.00985","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T07:30:36Z","timestamp":1526974236000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Comprehensive Antiretroviral Restriction Factor Profiling Reveals the Evolutionary Imprint of the ex Vivo and in Vivo IFN-\u03b2 Response in HTLV-1-Associated Neuroinflammation"],"prefix":"10.3389","volume":"9","author":[{"given":"Fabio E.","family":"Leal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraya Maria","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela A. S.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip M.","family":"Brailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio","family":"Gama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aluisio C.","family":"Segurado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esper G.","family":"Kallas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas F.","family":"Nixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Dierckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Khouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurgen","family":"Vercauteren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Galv\u00e3o-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui Andre","family":"Saraiva Raposo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Van Weyenbergh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,5,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/1742-4690-10-106","article-title":"Expression profile of host restriction factors in HIV-1 elite controllers","volume":"10","author":"Abdel-Mohsen","year":"2013","journal-title":"Retrovirology"},{"key":"B2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/QAD.0000000000000572","article-title":"Select host restriction factors are associated with HIV persistence during antiretroviral therapy","volume":"29","author":"Abdel-Mohsen","year":"2015","journal-title":"AIDS"},{"key":"B3","doi-asserted-by":"publisher","first-page":"15012","DOI":"10.1038\/nrdp.2015.12","article-title":"HTLV-1-associated myelopathy\/tropical spastic paraparesis","volume":"1","author":"Bangham","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e0005285","DOI":"10.1371\/journal.pntd.0005285","article-title":"Cytoplasmic localization of HTLV-1 HBZ protein: a biomarker of HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP)","volume":"11","author":"Baratella","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"13386","DOI":"10.1128\/JVI.02758-13","article-title":"Alpha interferon restricts human T-lymphotropic virus type 1 and 2 de novo infection through PKR activation","volume":"87","author":"Cachat","year":"2013","journal-title":"J. Virol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"958786","DOI":"10.1155\/2012\/958786","article-title":"Interferon Beta-1a improves urinary symptoms, reduces proviral load, and modifies the immune response in a patient with HAM\/TSP","volume":"2012","author":"Costa","year":"2012","journal-title":"Case Rep. Neurol. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0166-0934(01)00445-1","article-title":"Quantitation of HTLV-I proviral load by a TaqMan real-time PCR assay","volume":"102","author":"Dehee","year":"2002","journal-title":"J. Virol. Methods"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e519","DOI":"10.1038\/bcj.2016.126","article-title":"IFN-\u03b2 induces greater antiproliferative and proapoptotic effects and increased p53 signaling compared with IFN-\u03b1 in PBMCs of Adult T-cell Leukemia\/Lymphoma patients","volume":"7","author":"Dierckx","year":"2017","journal-title":"Blood Cancer J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.4049\/jimmunol.1701120","article-title":"ISG15-induced IL-10 Is a novel anti-inflammatory myeloid axis disrupted during active tuberculosis","volume":"200","author":"Dos Santos","year":"2018","journal-title":"J. Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1242\/jcs.167817","article-title":"MicroRNA-mediated regulation of p21 and TASK1 cellular restriction factors enhances HIV-1 infection","volume":"128","author":"Farberov","year":"2015","journal-title":"J. Cell Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3389\/fimmu.2017.00564","article-title":"Tripartite motif-containing protein 22 interacts with class II transactivator and orchestrates its recruitment in nuclear bodies containing TRIM19\/PML and cyclin T1","volume":"8","author":"Forlani","year":"2017","journal-title":"Front. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12967-016-0853-5","article-title":"The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells","volume":"14","author":"Forlani","year":"2016","journal-title":"J. Transl. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.3389\/fimmu.2017.01853","article-title":"Inhibiting the ins and outs of HIV replication: cell-intrinsic antiretroviral restrictions at the plasma membrane","volume":"8","author":"Foster","year":"2017","journal-title":"Front. Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.3389\/fmicb.2017.01800","article-title":"Time to Go back to the original name","volume":"8","author":"Gallo","year":"2017","journal-title":"Front. Microbiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1212\/WNL.46.4.1016","article-title":"Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial","volume":"46","author":"Izumo","year":"1996","journal-title":"Neurology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1742-4690-1-6","article-title":"The role of cyclin D2 and p21\/waf1 in human T-cell leukemia virus type 1 infected cells","volume":"1","author":"Kehn","year":"2004","journal-title":"Retrovirology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1742-4690-10-52","article-title":"Interferon-\u03b1 (IFN-\u03b1) suppresses HTLV-1 gene expression and cell cycling, while IFN-\u03b1 combined with zidovudine induces p53 signaling and apoptosis in HTLV-1-infected cells","volume":"10","author":"Kinpara","year":"2013","journal-title":"Retrovirology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1128\/JVI.02496-15","article-title":"TRIM5 retroviral restriction activity correlates with the ability to induce innate immune signaling","volume":"90","author":"Lascano","year":"2015","journal-title":"J. Virol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.chom.2014.05.011","article-title":"A cell-intrinsic inhibitor of HIV-1 reverse transcription in CD4(+) T cells from elite controllers","volume":"15","author":"Leng","year":"2014","journal-title":"Cell Host Microbe"},{"key":"B20","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1742-4690-8-94","article-title":"A whole genome screen for HIV restriction factors","volume":"8","author":"Liu","year":"2011","journal-title":"Retrovirology"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1084\/jem.182.5.1517","article-title":"Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma","volume":"182","author":"Lu","year":"1995","journal-title":"J. Exp. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12977-015-0165-5","article-title":"Identification of potential HIV restriction factors by combining evolutionary genomic signatures with functional analyses","volume":"12","author":"McLaren","year":"2015","journal-title":"Retrovirology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1742-2094-11-18","article-title":"CD80+ and CD86+ B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy\/tropical spastic paraparesis and multiple sclerosis","volume":"11","author":"Menezes","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e1729","DOI":"10.1371\/journal.pntd.0001729","article-title":"Ascorbic acid has superior ex vivo antiproliferative, cell death-inducing and immunomodulatory effects over IFN-\u03b1 in HTLV-1-associated myelopathy","volume":"6","author":"Moens","year":"","journal-title":"PLoS Negl. Trop. Dis"},{"key":"B25","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/1743-422X-9-171","article-title":"Simultaneous RNA quantification of human and retroviral genomes reveals intact interferon signaling in HTLV-1-infected CD4+ T cell lines","volume":"9","author":"Moens","year":"","journal-title":"Virol. J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nature06553","article-title":"Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu","volume":"451","author":"Neil","year":"2008","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e74063","DOI":"10.1371\/journal.pone.0074063","article-title":"Restriction genes for retroviruses influence the risk of multiple sclerosis","volume":"8","author":"Nexo","year":"2013","journal-title":"PLoS ONE"},{"key":"B28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12977-017-0350-9","article-title":"Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy\/tropical spastic paraparesis","volume":"14","author":"Nozuma","year":"2017","journal-title":"Retrovirology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1002\/ana.20429","article-title":"Interferon-beta1a therapy in human T-lymphotropic virus type I-associated neurologic disease","volume":"57","author":"Oh","year":"2005","journal-title":"Ann. Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1093\/molbev\/msp197","article-title":"Evolutionary trajectories of primate genes involved in HIV pathogenesis","volume":"26","author":"Ortiz","year":"2009","journal-title":"Mol. Biol. Evol."},{"key":"B31","first-page":"191","article-title":"Review of WHO Kagoshima Meeting and diagnostic guidelines for HAM\/TSP","volume-title":"Human Retrovirology: HTLV","author":"Osame","year":"1990"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0140-6736(86)91298-5","article-title":"HTLV-I associated myelopathy, a new clinical entity","volume":"1","author":"Osame","year":"1986","journal-title":"Lancet"},{"key":"B33","doi-asserted-by":"publisher","first-page":"11924","DOI":"10.1128\/JVI.02128-13","article-title":"Effects of cellular activation on anti-HIV-1 restriction factor expression profile in primary cells","volume":"87","author":"Raposo","year":"","journal-title":"J. Virol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"11624","DOI":"10.1128\/JVI.01771-14","article-title":"Dynamic regulation of host restriction factor expression over the course of HIV-1 infection in vivo","volume":"88","author":"Raposo","year":"2014","journal-title":"J. Virol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1189\/jlb.0313150","article-title":"Increased expression of intrinsic antiviral genes in HLA-B*57-positive individuals","volume":"94","author":"Raposo","year":"","journal-title":"J. Leukoc. Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e1000781","DOI":"10.1371\/journal.ppat.1000781","article-title":"Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals","volume":"6","author":"Rotger","year":"2010","journal-title":"PLoS Pathog."},{"key":"B37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1742-4690-6-19","article-title":"In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy\/tropical spastic paraparesis (HAM\/TSP)","volume":"6","author":"Saito","year":"2009","journal-title":"Retrovirology"},{"key":"B38","doi-asserted-by":"publisher","first-page":"e1006597","DOI":"10.1371\/journal.ppat.1006597","article-title":"IL-10-mediated signals act as a switch for lymphoproliferation in Human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways","volume":"13","author":"Sawada","year":"2017","journal-title":"PLoS Pathog."},{"key":"B39","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nature12862","article-title":"Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity","volume":"505","author":"Schoggins","year":"2014","journal-title":"Nature"},{"key":"B40","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature09907","article-title":"A diverse range of gene products are effectors of the type I interferon antiviral response","volume":"472","author":"Schoggins","year":"2011","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1128\/JVI.03603-13","article-title":"TRIM5alpha and TRIM22 are differentially regulated according to HIV-1 infection phase and compartment","volume":"88","author":"Singh","year":"2014","journal-title":"J. Virol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.3389\/fmicb.2017.01425","article-title":"The exceptional oncogenicity of HTLV-1","volume":"8","author":"Tagaya","year":"2017","journal-title":"Front. Microbiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"e1002480","DOI":"10.1371\/journal.ppat.1002480","article-title":"Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy","volume":"8","author":"Tattermusch","year":"2012","journal-title":"PLoS Pathog."},{"key":"B44","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.meegid.2004.11.001","article-title":"Adaptation, co-evolution, and human susceptibility to HIV-1 infection","volume":"5","author":"Telenti","year":"2005","journal-title":"Infect. Genet. Evol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"10719","DOI":"10.1128\/JVI.00813-11","article-title":"Major histocompatibility complex class II transactivator CIITA is a viral restriction factor that targets human T-cell lymphotropic virus type 1 Tax-1 function and inhibits viral replication","volume":"85","author":"Tosi","year":"2011","journal-title":"J. Virol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1590\/S0036-46652014000500013","article-title":"Interferon beta-1a treatment in HTLV-1-associated myelopathy\/tropical spastic paraparesis: a case report","volume":"56","author":"Viana","year":"2014","journal-title":"Rev. Inst. Med. Trop. Sao Paulo"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2018.00985\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T07:30:43Z","timestamp":1526974243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2018.00985\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,22]]},"references-count":46,"alternative-id":["10.3389\/fmicb.2018.00985"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2018.00985","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,22]]},"article-number":"985"}}